Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
3034 results found
2025 ∙ Goldsmith, J. J. Tavlian, S. Vu, C. Regan, A. K. Campbell, P. T. Sullivan, S. G.
Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza: A Systematic Review and Meta-Analysis
Newborn Children Influenza Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Abo Zeid, M. Elrosasy, A. Farho, M. A. Rifai, M. Aboelkhier, M. M. Elkhrashy, M. N. Zabady, A. H. Zaki, M. S. A. Hamed, E. M. Dawood, S. A. Abuzaid, Y.
Comparison of safety and immunogenicity between Healive, Havrix and live attenuated Hepatitis A vaccines in pediatric population: a systematic review with meta-analysis
All age groups Hepatitis A Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Fletcher, M. A. Okasha, O. Baay, M. Syrochkina, M. Hayford, K.
Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022
All age groups Pneumococcal disease Administration Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Wang, Z. Zhang, H. Zhu, Y. Jiang, Y. Yang, D. Zou, X. Fang, Y.
Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females
All age groups Human papillomavirus (HPV) Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Wang, W. Sawleshwarkar, S. Piraveenan, M.
Computational approaches of modelling human papillomavirus transmission and prevention strategies: a systematic review
All age groups Human papillomavirus (HPV) Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Samal, J. Preetha, G. S. Kumar, R. P. Lakshman, N. Dehury, R. K. Singh, H.
Coronavirus Disease 2019 Vaccine Hesitancy and Acceptance among the Indian Population: A Systematic Review and Meta-Analysis
South-East Asia India Adolescents Adults Older adults Healthcare workers Parents/caregivers Pregnant women COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Felsher, M. Fisher-Borne, M. Malik, T. Santpurkar, N. Martin, S. Zaidi, O. Wang, W. Palmer, C.
Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review
Children Adolescents Adults Older adults Human papillomavirus (HPV) Economic aspects Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Fu, X. Xia, Y. Zhou, W. Lu, Y.
Cost-effectiveness of human papillomavirus vaccination among girls aged 9-16 years in China: a meta-analysis
Western Pacific China Adolescents Human papillomavirus (HPV) Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Tamir, T. T. Tekeba, B. Techane, M. A. Alemu, T. G. Wubneh, C. A. Wassie, Y. A.
Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12-23 months in 41 low- and middle-income countries: A Meta-analysis of demographic and health survey reports between 2015 and 2025
Newborn Children Low and Middle Income Countries Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Cheuyem, F. Z. L. Amani, A. Achangwa, C. Ajong, B. N. Minkandi, C. A. Zeh, M. M. M. K. Ntsek, L. L. E. Essomba, J. P. Jiogue, R. C. Ndagijimana, O. Nchanji, N. E. Danwang, C.
COVID- 19 vaccine uptake and its determinants in Cameroon: a systematic review and meta-analysis (2021-2024)
Africa Cameroon All age groups Healthcare workers COVID-19 Coverage Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...